Skip to product information
1 of 1

GeneBio Systems

CTDP1 Polyclonal Antibody

CTDP1 Polyclonal Antibody

SKU:E-AB-19860

Regular price $604.00 USD
Regular price Sale price $604.00 USD
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: CTDP1

Target Synonym: CCFDN;CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) phosphatase; subunit 1;CTD of POLR2A; phosphatase of; subunit 1;CTDP1;CTDP1;EC 3.1.3.16 ;RNA polymerase II subunit A C terminal domain phosphatase;RNA polymerase II subunit A C-terminal domain phosphatase;Serine phosphatase FCP1a;TFIIF associating CTD phosphatase ;TFIIF-associating CTD phosphatase 1 ;TFIIF-associating CTD phosphatase;Transcription factor IIF-associating CTD phosphatase 1

Research Areas: Signal Transduction;Epigenetics and Nuclear Signaling

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: Q9Y5B0

Accession:

Background: This gene encodes a protein which interacts with the carboxy-terminus of the RAP74 subunit of transcription initiation factor TFIIF, and functions as a phosphatase that processively dephosphorylates the C-terminus of POLR2A (a subunit of RNA polymerase II), making it available for initiation of gene expression. Mutations in this gene are associated with congenital cataracts, facial dysmorphism and neuropathy syndrome (CCFDN). Alternatively spliced transcript variants encoding different isoforms have been described for this gene.

Concentration: 2.16 mg/mL

Immunogen: Synthetic peptide of human CTDP1

Buffer: PBS with 0.05% NaN3 and 40% Glycerol,pH7.4

Purification method: Antigen affinity purification

Dilution: IHC 1:50-1:300

Calculated MW:

ObservedMW:

View full details